Aid cuts by the UK, US, and Europe risk worsening antimicrobial resistance rates worldwide. Economic losses by 2050 could reach $722bn in China, $295.7bn in the US, and $58.6bn in the UK. Protecting Antimicrobial Resistance (AMR) programmes is essential to prevent millions of deaths.
